Right on, Mr. Corleone. And if Gilead, J&J, or any other company buys ENZC and we get shares in the buying company, I am not selling a single share! ... because the buying company will likely double or triple in a year (or less) with all the massively disruptive biotech they just bought!!! Any mid-cap biotech or pharma company that buys ENZC is buying a ticket to the big leagues: large cap pharma.